Merck/AstraZeneca lisinopril exclusivity
Executive Summary
Merck and AstraZeneca receive pediatric exclusivity through June 29 on lisinopril products (Merck's Prinivil; AstraZeneca's Zestril and Zestoretic). The companies are seeking to have the pediatric data added to labeling; FDA is reviewing supplemental NDAs. AstraZeneca licenses lisinopril from Merck...